<p>随着亚洲市场在科技行业的乐观情绪和不断变化的经济政策中不断前行，投资者密切关注与这些趋势相符的增长机会。在这种背景下，拥有高内部持股的公司往往成为潜在的增长候选者，因为这可能表明与企业关系最密切的人对其强烈信心。</p>
<h3>亚洲高内部持股的十大增长公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>JV Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们筛选的 623 只高内部持股快速增长的亚洲公司的完整名单。</p>
<p>让我们回顾一些我们筛选股票中的显著选择。</p>
<h2>ROBOTIS (KOSDAQ:A108490)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> ROBOTIS 有限公司在韩国提供机器人解决方案，市值为 39.1 亿韩元。</p>
<p><strong>运营：</strong> 该公司通过开发、制造和销售个人机器人产生 341.1 亿韩元的收入。</p>
<p><strong>内部持股：</strong> 24.2%</p>
<p><strong>盈利增长预测：</strong> 每年 90.8%。</p>
<p>ROBOTIS 展现出显著的增长潜力，今年实现盈利，预计盈利将以每年 90.8% 的速度大幅增长，超过韩国市场平均水平。收入也预计将以每年 51.9% 的速度快速增长。尽管最近股价波动剧烈，但该公司在最新的盈利结果中报告了从亏损到盈利的显著转变，并完成了一笔约 2098.5 亿韩元的后续股权发行，增强了其未来扩张的财务状况。</p>
<ul>
<li>在我们的盈利增长报告中更详细地了解 ROBOTIS 的潜力。</li>
<li>我们的综合估值报告提出 ROBOTIS 的当前价格可能高于其财务状况所能合理支持的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="1048" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth"/></p>
<p>KOSDAQ:A108490 截至 2026 年 1 月的盈利和收入增长</p>
<h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> SBT Ultrasonic Technology 有限公司专注于全球超声设备的研究、开发、设计、生产和销售，市值为 162.7 亿人民币。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其机械与工业设备部门，产生了 6.9691 亿人民币的收入。</p>
<p><strong>内部持股：</strong> 21.2%</p>
<p><strong>盈利增长预测：</strong> 每年 37.1%。</p>
<p>SBT Ultrasonic Technology 展现出令人印象深刻的增长，2025 年前九个月的盈利飙升至 9403 万人民币，较去年同期的 2045 万人民币大幅增长。收入从 4.0817 亿人民币增加至 5.2052 亿人民币。尽管最近股价波动剧烈，预测显示其收入和盈利增长分别超过市场平均水平，达到 32.5% 和 37.1% 的年增长率，突显其在亚洲竞争激烈的市场中的强劲增长轨迹。</p>
<ul>
<li>点击探索我们在 SBT Ultrasonic Technology 盈利增长报告中的详细发现。</li>
<li>我们编制的估值报告表明，SBT Ultrasonic Technology 当前的价格可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="636" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown"/></p>
<p>SHSE:688392 截至 2026 年 1 月的持股结构</p>
<h2>Winning Health Technology Group (SZSE:300253)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Winning Health Technology Group 有限公司为中国的医疗和健康机构提供数字健康服务，市值为 306.9 亿人民币。</p>
<p><strong>运营：</strong> Winning Health Technology Group 有限公司通过为中国各地的医疗和健康机构提供量身定制的数字健康服务来产生收入。</p>
<p><strong>内部持股：</strong> 22.2%</p>
<p><strong>盈利增长预测：</strong> 每年 76.7%。</p>
<p>Winning Health Technology Group 的交易价格显著低于其估计的公允价值，表明潜在的低估。尽管在 2025 年前九个月出现了 2.4139 亿人民币的净亏损，但预计该公司将在三年内实现盈利，收入年增长预计为 20.3%，超过市场平均水平。然而，投资者应注意股价波动较大，预测的股本回报率为 7.8%。</p>
<ul>
<li>在这里深入了解 Winning Health Technology Group 的具体情况，查看我们的详细增长预测报告。</li>
<li>我们的估值报告显示 Winning Health Technology Group 可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="1048" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300253 截至 2026 年 1 月的盈利和收入增长</p>
<h2>抓住机会</h2>
<ul>
<li>在这里探索我们筛选的 623 个高内部持股快速增长的亚洲公司。</li>
<li>对其他选择感兴趣？寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有引用的预测收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>

卫宁健康

锐明技术

<p>随着亚洲市场在科技乐观情绪中蓬勃发展，拥有高内部持股的公司正吸引投资者的关注。值得注意的公司包括 UTI、锐明技术和 Phison Electronics，展现出显著的盈利增长。ROBOTIS 的内部持股比例为 24.2%，预计年盈利增长达到 90.8%，而 SBT 超声波技术预计为 37.1%。尽管卫宁健康近期出现亏损，但预计在三年内实现盈利，增长预测为 76.7%。这些公司突显了亚洲不断发展的经济格局中的潜在增长机会</p>

<p>As Asian markets continue to navigate a landscape marked by optimism in the tech sector and evolving economic policies, investors are keenly observing growth opportunities that align with these trends. In this context, companies with high insider ownership often stand out as potential candidates for growth, as they may indicate strong confidence from those closest to the business.</p>
<div class="lb-trans"><p>随着亚洲市场在科技行业的乐观情绪和不断变化的经济政策中不断前行，投资者密切关注与这些趋势相符的增长机会。在这种背景下，拥有高内部持股的公司往往成为潜在的增长候选者，因为这可能表明与企业关系最密切的人对其强烈信心。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亚洲高内部持股的十大增长公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>JV Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 623 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们筛选的 623 只高内部持股快速增长的亚洲公司的完整名单。</p>
</div><p>Let's review some notable picks from our screened stocks.</p>
<div class="lb-trans"><p>让我们回顾一些我们筛选股票中的显著选择。</p>
</div><h2>ROBOTIS (KOSDAQ:A108490)</h2>
<div class="lb-trans"><h2>ROBOTIS (KOSDAQ:A108490)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> ROBOTIS Co., Ltd. offers robotic solutions in South Korea and has a market cap of ₩3.91 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ROBOTIS 有限公司在韩国提供机器人解决方案，市值为 39.1 亿韩元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of ₩34.11 billion from developing, manufacturing, and selling personal robots.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过开发、制造和销售个人机器人产生 341.1 亿韩元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 24.2%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 24.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 90.8% p.a.</p>
<div class="lb-trans"><p><strong>盈利增长预测：</strong> 每年 90.8%。</p>
</div><p>ROBOTIS has demonstrated significant growth potential, becoming profitable this year with earnings forecasted to grow substantially at 90.8% per year, outpacing the KR market average. Revenue is also expected to increase rapidly by 51.9% annually. Despite a highly volatile share price recently, the company reported a notable swing from loss to profit in its latest earnings results and completed a follow-on equity offering worth approximately ₩209.85 billion, enhancing its financial position for future expansion.</p>
<div class="lb-trans"><p>ROBOTIS 展现出显著的增长潜力，今年实现盈利，预计盈利将以每年 90.8% 的速度大幅增长，超过韩国市场平均水平。收入也预计将以每年 51.9% 的速度快速增长。尽管最近股价波动剧烈，但该公司在最新的盈利结果中报告了从亏损到盈利的显著转变，并完成了一笔约 2098.5 亿韩元的后续股权发行，增强了其未来扩张的财务状况。</p>
</div><ul>
<li>Take a closer look at ROBOTIS' potential here in our earnings growth report.</li>
<li>Our comprehensive valuation report raises the possibility that ROBOTIS is priced higher than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的盈利增长报告中更详细地了解 ROBOTIS 的潜力。</li>
<li>我们的综合估值报告提出 ROBOTIS 的当前价格可能高于其财务状况所能合理支持的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth"/></p>
<p>KOSDAQ:A108490 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>KOSDAQ:A108490 截至 2026 年 1 月的盈利和收入增长</p>
</div><h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
<div class="lb-trans"><h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> SBT Ultrasonic Technology Co., Ltd. focuses on the research, development, design, production, and sale of ultrasonic equipment globally and has a market cap of CN¥16.27 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> SBT Ultrasonic Technology 有限公司专注于全球超声设备的研究、开发、设计、生产和销售，市值为 162.7 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Machinery &amp; Industrial Equipment segment, which generated CN¥696.91 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其机械与工业设备部门，产生了 6.9691 亿人民币的收入。</p>
</div><p><strong>Insider Ownership:</strong> 21.2%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 21.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 37.1% p.a.</p>
<div class="lb-trans"><p><strong>盈利增长预测：</strong> 每年 37.1%。</p>
</div><p>SBT Ultrasonic Technology has shown impressive growth, with earnings soaring to CNY 94.03 million for the first nine months of 2025, up from CNY 20.45 million a year ago. Revenue increased to CNY 520.52 million from CNY 408.17 million over the same period. Despite recent share price volatility, forecasts suggest robust revenue and earnings growth exceeding market averages at 32.5% and 37.1% annually respectively, underscoring its strong growth trajectory in Asia's competitive landscape.</p>
<div class="lb-trans"><p>SBT Ultrasonic Technology 展现出令人印象深刻的增长，2025 年前九个月的盈利飙升至 9403 万人民币，较去年同期的 2045 万人民币大幅增长。收入从 4.0817 亿人民币增加至 5.2052 亿人民币。尽管最近股价波动剧烈，预测显示其收入和盈利增长分别超过市场平均水平，达到 32.5% 和 37.1% 的年增长率，突显其在亚洲竞争激烈的市场中的强劲增长轨迹。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in SBT Ultrasonic Technology's earnings growth report.</li>
<li>The valuation report we've compiled suggests that SBT Ultrasonic Technology's current price could be inflated.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在 SBT Ultrasonic Technology 盈利增长报告中的详细发现。</li>
<li>我们编制的估值报告表明，SBT Ultrasonic Technology 当前的价格可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown"/></p>
<p>SHSE:688392 Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>SHSE:688392 截至 2026 年 1 月的持股结构</p>
</div><h2>Winning Health Technology Group (SZSE:300253)</h2>
<div class="lb-trans"><h2>Winning Health Technology Group (SZSE:300253)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Winning Health Technology Group Co., Ltd. offers digital health services to medical and health institutions in China, with a market cap of CN¥30.69 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Winning Health Technology Group 有限公司为中国的医疗和健康机构提供数字健康服务，市值为 306.9 亿人民币。</p>
</div><p><strong>Operations:</strong> Winning Health Technology Group Co., Ltd. generates revenue by providing digital health services tailored for medical and health institutions across China.</p>
<div class="lb-trans"><p><strong>运营：</strong> Winning Health Technology Group 有限公司通过为中国各地的医疗和健康机构提供量身定制的数字健康服务来产生收入。</p>
</div><p><strong>Insider Ownership:</strong> 22.2%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 22.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 76.7% p.a.</p>
<div class="lb-trans"><p><strong>盈利增长预测：</strong> 每年 76.7%。</p>
</div><p>Winning Health Technology Group is trading significantly below its estimated fair value, indicating potential undervaluation. Despite a recent net loss of CNY 241.39 million for the first nine months of 2025, the company is expected to achieve profitability within three years with revenue growth projected at 20.3% annually, surpassing market averages. However, investors should note the high share price volatility and low forecasted return on equity of 7.8%.</p>
<div class="lb-trans"><p>Winning Health Technology Group 的交易价格显著低于其估计的公允价值，表明潜在的低估。尽管在 2025 年前九个月出现了 2.4139 亿人民币的净亏损，但预计该公司将在三年内实现盈利，收入年增长预计为 20.3%，超过市场平均水平。然而，投资者应注意股价波动较大，预测的股本回报率为 7.8%。</p>
</div><ul>
<li>Dive into the specifics of Winning Health Technology Group here with our thorough growth forecast report.</li>
<li>Our valuation report here indicates Winning Health Technology Group may be overvalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 Winning Health Technology Group 的具体情况，查看我们的详细增长预测报告。</li>
<li>我们的估值报告显示 Winning Health Technology Group 可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300253 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>SZSE:300253 截至 2026 年 1 月的盈利和收入增长</p>
</div><h2>Seize The Opportunity</h2>
<div class="lb-trans"><h2>抓住机会</h2>
</div><ul>
<li>Explore the 623 names from our Fast Growing Asian Companies With High Insider Ownership screener here.</li>
<li>Curious About Other Options? Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里探索我们筛选的 623 个高内部持股快速增长的亚洲公司。</li>
<li>对其他选择感兴趣？寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有引用的预测收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div>

三家内部持股比例高的亚洲成长型公司